Insider · CIK 0001711393

Shabet Rose Sharon

CIK 0001711393 Name as filed on the most recent filing

Filed as Shabet Rose Sharon (64)

140 transaction lines · from 64 filings · filed 2018-04-05 to 2025-10-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-10-07 S, Open-market sale Inhibrx Biosciences, Inc.INBX 3 lines 11,287,500, disposed Open Form 4 filing 0000905148-25-003555
2025-06-27 S, Open-market sale BridgeBio Pharma, Inc.BBIO 154,000,000, disposed Open Form 4 filing 0000905148-25-002297
2025-01-31 S, Open-market sale BridgeBio Pharma, Inc.BBIO 106,989,998, disposed Open Form 4 filing 0000905148-25-000306
2024-06-17 S, Open-market sale APi Group CorpAPG 2 lines 74,460,483, disposed Open Form 4 filing 0000905148-24-001732
2024-06-17 S, Open-market sale APi Group CorpAPG 2 lines 74,460,483, disposed Open Form 4 filing 0000905148-24-001733
2024-03-05 S, Open-market sale APi Group CorpAPG 2 lines 104,072,632, disposed Open Form 4 filing 0000905148-24-000919
2024-03-05 S, Open-market sale APi Group CorpAPG 2 lines 104,072,632, disposed Open Form 4 filing 0000905148-24-000920
2024-01-04 S, Open-market sale 4D Molecular Therapeutics, Inc.FDMT 10,546,200, disposed Open Form 4 filing 0000905148-24-000092
2024-01-02 S, Open-market sale APi Group CorpAPG 3 lines 203,450,000, disposed Open Form 4 filing 0000905148-24-000079
2024-01-02 S, Open-market sale APi Group CorpAPG 3 lines 203,450,000, disposed Open Form 4 filing 0000905148-24-000080
2023-09-19 P, Open-market purchase RayzeBio, Inc.RYZB 2 lines 25,000,002, acquired Open Form 4 filing 0000905148-23-000959
2023-09-19 P, Open-market purchase RayzeBio, Inc.RYZB 2 lines 25,000,002, acquired Open Form 4 filing 0000905148-23-000958
2023-08-28 P, Open-market purchase Inhibrx, Inc.INBX 9,899,982, acquired Open Form 4 filing 0000905148-23-000804
2023-07-18 S, Open-market sale BridgeBio Pharma, Inc.BBIO 52,500,000, disposed Open Form 4 filing 0001140361-23-035288
2023-06-22 S, Open-market sale Roivant Sciences Ltd.ROIV 4 lines 128,700,000, disposed Open Form 4 filing 0001140361-23-031459
2023-06-22 S, Open-market sale Roivant Sciences Ltd.ROIV 4 lines 128,700,000, disposed Open Form 4 filing 0001140361-23-031456
2023-05-09 P, Open-market purchase 4D Molecular Therapeutics, Inc.FDMT 13,600,000, acquired Open Form 4 filing 0001140361-23-024202
2022-11-02 P, Open-market purchase Frazier Lifesciences Acquisition CorpFLAC 2 lines 8,538,385, acquired Open Form 4 filing 0001140361-22-040057
2022-10-07 P, Open-market purchase Inhibrx, Inc.INBX 2 lines 39,999,857, acquired Open Form 4 filing 0001140361-22-036956
2022-09-09 S, Open-market sale Amylyx Pharmaceuticals, Inc.AMLX 6 lines 21,159,753, disposed Open Form 4 filing 0001140361-22-032970
2022-09-08 S, Open-market sale Amylyx Pharmaceuticals, Inc.AMLX 4,634,431, disposed Open Form 4 filing 0001140361-22-032970
2022-09-08 S, Open-market sale Amylyx Pharmaceuticals, Inc.AMLX 3,580,773, disposed Open Form 4 filing 0001140361-22-032970
2022-09-08 S, Open-market sale Amylyx Pharmaceuticals, Inc.AMLX 3,058,582, disposed Open Form 4 filing 0001140361-22-032970
2022-09-08 S, Open-market sale Amylyx Pharmaceuticals, Inc.AMLX 2,202,091, disposed Open Form 4 filing 0001140361-22-032970
2022-09-08 S, Open-market sale Amylyx Pharmaceuticals, Inc.AMLX 2,188,493, disposed Open Form 4 filing 0001140361-22-032970

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Shabet Rose Sharon, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001711393

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.